Laura Desmond - Sep 12, 2023 Form 4 Insider Report for DoubleVerify Holdings, Inc. (DV)

Role
Director
Signature
/s/ Andrew E. Grimmig, as Attorney-in-Fact for Laura B. Desmond
Stock symbol
DV
Transactions as of
Sep 12, 2023
Transactions value $
-$316,182
Form type
4
Date filed
9/14/2023, 04:01 PM
Previous filing
Aug 24, 2023
Next filing
Sep 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DV Common Stock Options Exercise $22.1K +11K +6.14% $2.01* 190K Sep 12, 2023 By Trust F1
transaction DV Common Stock Sale -$338K -11K -5.79% $30.75 179K Sep 12, 2023 By Trust F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DV Options (Rights to Buy) Options Exercise $0 -11K -2.48% $0.00 434K Sep 12, 2023 Common Stock 11K $2.01 By Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares and options held by the Laura B. Desmond Revocable Trust for which Ms. Desmond is trustee.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2022.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.60 to $30.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 Represents non-qualified stock options granted on September 20, 2017 that vested on November 22, 2021 upon Providence VII U.S. Holdings L.P. receiving cumulative cash proceeds in respect of its investment in the Issuer equal to two times its aggregate cash investment in the Issuer.